Related Experiment Videos
[Home respiratory care]
1ANTADIR (Association fédérative Nationale pour le Traitement A Domicile de l'Insuffisance Respiratoire chronique), 66 boulevard Saint Michel, 75006 Paris, France.
Therapie
|July 27, 2001
Summary
Home respiratory care (HRC) in France has surged tenfold since 1980, now serving 120,000 patients with chronic severe lung disease (CSLD) and sleep apnea syndrome (SAS). This growth necessitates coordinated, cost-effective care models outside hospitals.
Area of Science:
- Respiratory Medicine
- Public Health
Context:
- Home respiratory care (HRC) in France has seen a tenfold increase since 1980, reaching approximately 120,000 patients.
- The primary conditions managed are chronic severe lung disease (CSLD) and sleep apnea syndrome (SAS).
- The mean age of patients is increasing, with CSLD patients averaging 67 years and SAS patients 58 years.
Purpose:
- To describe the evolution and current state of home respiratory care in France.
- To highlight the key patient populations and treatment modalities.
- To underscore the logistical and coordination challenges associated with long-term HRC.
Summary:
- CSLD is primarily treated with long-term oxygen therapy and assisted ventilation.
- Sleep apnea syndrome (SAS) is managed with continuous positive airway pressure (CPAP), available since 1985.
- The long-term nature and daily duration of HRC treatments (12-24h for CSLD, 5-8h nightly for SAS) make hospitalization impractical.
Impact:
- Effective HRC requires complex coordination among medical and social workers for cost-effective delivery.
- France utilizes a well-established not-for-profit network, ANTADIR, and regional HRC services for patient care.
- Physician involvement, often from university hospitals, is crucial for administering specialized HRC services.